作者:Robert T. Shuman、Robert B. Rothenberger、Charles S. Campbell、Gerald F. Smith、Donetta S. Gifford-Moore、Paul D. Gesellchen
DOI:10.1021/jm00055a002
日期:1993.2
potent direct inhibition of thrombin. This distinction offers important insight for the design of more potent and selective serine proteaseinhibitors which may be useful pharmacological tools and hold promise for development of clinically useful agents. The structure-activityrelationships (SAR) on a series of anticoagulant peptides with high selectivity for the enzyme thrombin are discussed. The SAR